Verismo Therapeutics
Clinical trials sponsored by Verismo Therapeutics, explained in plain language.
-
New CAR T-Cell therapy aims to tackle tough lymphoma
Disease control Recruiting nowThis early-stage study tests a new treatment called SynKIR-310 for adults with B-cell non-Hodgkin lymphoma that has come back or not responded to at least two prior therapies. The treatment uses a patient's own immune cells, modified to better recognize and attack cancer cells. T…
Phase: PHASE1 • Sponsor: Verismo Therapeutics • Aim: Disease control
Last updated May 17, 2026 02:03 UTC
-
New CAR t therapy targets three tough cancers in early trial
Disease control Recruiting nowThis early-stage study tests a one-time treatment called SynKIR-110, made from a patient's own immune cells modified to attack cancer cells that have a protein called mesothelin. It is for adults with advanced ovarian cancer, bile duct cancer, or mesothelioma that has come back a…
Phase: PHASE1 • Sponsor: Verismo Therapeutics • Aim: Disease control
Last updated May 04, 2026 16:25 UTC